Oligonucleotides represent a fairly new class of therapeutic substances for which binding regulatory and analytical standards are still pending until to date.
LLS Health has been a leader in the field of women's health, contributing to substantial advancements in the breadth of intravaginal rings and implantable device designs. In this article, Jite Okoh and Nick DiFranc...
Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance.
Biocon Biologics and Serum Institute Life Sciences Private Limited announced a strategic alliance. BBL will get committed access to a 100 million doses of vaccines per annum for 15 years...
RedHill Biopharma Reports Top Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients.
RedHill Biopharma announced preliminary top-line data from the 475 patient global Phase 2/3 study with opaganib in hospitalized patients with severe COVID...
Pfizer and BioNTech Announce Positive Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years.
Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11...